Simplifying Science™
Information displayed below is a subset of the entire knowledge base and may be incomplete intensionally or inadvertently. If you detect a serious error or want access to the complete knowledge base, please contact us.
Hemoglobin crosfumaril is a drug used to treat sickle cell anemia, a genetic disorder that affects red blood cells. It works by increasing the production of fetal hemoglobin, which helps to reduce the sickling of red blood cells. The side effects of hemoglobin crosfumaril include headache, nausea, vomiting, abdominal pain, dizziness, and fatigue. It may also cause anemia, low white blood cell count, and increased risk of infection.
Associated brand names: ▸ Crizanlizumab ▸ Adakveo ▸ Fibryga ▸ Sanglizumab-Aqg
All of the following must be considered when interpreting clinical findings
and are too extensive to be covered on this site:
